Who invested in Moonlight Therapeutics?
Moonlight Therapeutics's investors include B Capital, SOSV and National Institute of Allergy and Infectious Diseases.

United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$2.4Mraised across 2 rounds since 2024, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $2.4M sold, first sale Aug 2024
From Moonlight Therapeutics's own website: 2 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Moonlight Therapeutics's investors include B Capital, SOSV and National Institute of Allergy and Infectious Diseases.
Moonlight Therapeutics has raised $2.4M across 2 rounds since 2024. One round did not disclose an amount, so the total is a floor.
Moonlight Therapeutics's most recent round was a Venture in Oct 2025.
Moonlight Therapeutics's largest round on record is $2.4M (Venture), in Aug 2024.
Moonlight Therapeutics's first round on record, in Aug 2024, was backed by B Capital and National Institute of Allergy and Infectious Diseases.
Moonlight Therapeutics's latest named round is a Venture, in Oct 2025.
Moonlight Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.